Further funding for HI-STEM

The Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) will receive funding from the Dietmar Hopp Foundation for another five years. The HI-STEM was established in October 2008 by the Foundation and the German Cancer Research Center with the aim of rendering results from stem cell research fit for application in cancer treatment medicine. Innovative diagnostics and approaches to treatment are to improve the survival rate of cancer patients. The total sum invested in the HI-STEM by the Dietmar Hopp Foundation amounts to 15 million Euro.

back